Product Description: Carbidopa-d3-1 is the deuterium labeled Carbidopa (HY-B0311). Carbidopa, a peripheral decarboxylase inhibitor, can be used for the research of Parkinson's disease. Carbidopa is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa inhibits pancreatic cancer cell and tumor growth[1][2].
Applications: Neuroscience-Neuromodulation
Formula: C10H11D3N2O4
References: [1]Aryl Hydrocarbon Receptor/[2]Fermaglich J. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa. Med Ann Dist Columbia. 1974;43(12):587-591.
Molecular Weight: 229.25
Research Area: Neurological Disease
Solubility: 10 mM in DMSO
Target: Aryl Hydrocarbon Receptor;Isotope-Labeled Compounds